ECZACIBASI YATIRIM
185.40
17-February-25 02:48:52
15 minutes delayed
Stocks
+1.10
+0.60%
Today's range
184.40 - 185.90
ISIN
TRAECZYT91Q5
Source
Borsa Istanbul
-
17 Feb 2025 02:56:12 By Buzz FX
-
HSBC (HSBC) Expected to Announce Quarterly Earnings on Wednesday
17 Feb 2025 02:56:12 By Buzz FX
-
National Bank Financial Estimates TSE:CMG FY2025 Earnings
17 Feb 2025 02:56:12 By Buzz FX
-
The Chemours Company (NYSE:CC) Receives Average Rating of "Hold" from Brokerages
17 Feb 2025 02:56:12 By Buzz FX
-
Williams-Sonoma, Inc. (NYSE:WSM) Receives Average Rating of "Hold" from Brokerages
17 Feb 2025 02:56:12 By Buzz FX
-
17 Feb 2025 02:56:12 By Buzz FX
-
National Bank Financial Forecasts Higher Earnings for TELUS
17 Feb 2025 02:56:12 By Buzz FX
-
Zacks Research Issues Pessimistic Estimate for RLI Earnings
17 Feb 2025 02:56:12 By Buzz FX
-
FY2025 EPS Estimates for Aya Gold & Silver Cut by Cormark
17 Feb 2025 02:56:12 By Buzz FX
-
Biogen Inc. (NASDAQ:BIIB) Given Average Recommendation of "Hold" by Brokerages
17 Feb 2025 02:56:12 By Buzz FX
-
Saia, Inc. (NASDAQ:SAIA) Receives Average Rating of "Moderate Buy" from Analysts
17 Feb 2025 02:56:12 By Buzz FX
-
Dana Incorporated (NYSE:DAN) Given Consensus Rating of "Moderate Buy" by Brokerages
17 Feb 2025 02:56:12 By Buzz FX
-
Olin Co. (NYSE:OLN) Receives Consensus Rating of "Hold" from Analysts
17 Feb 2025 02:56:12 By Buzz FX
-
Polaris Inc. (NYSE:PII) Receives Average Recommendation of "Hold" from Analysts
17 Feb 2025 02:56:12 By Buzz FX
-
Danaher Co. (NYSE:DHR) Receives Average Rating of "Moderate Buy" from Analysts
17 Feb 2025 02:56:12 By Buzz FX
-
Dun & Bradstreet Holdings, Inc. (NYSE:DNB) Given Average Recommendation of "Hold" by Brokerages
17 Feb 2025 02:56:12 By Buzz FX
-
Sempra (NYSE:SRE) Receives Consensus Recommendation of "Buy" from Analysts
17 Feb 2025 02:56:12 By Buzz FX
-
Emerson Electric Co. (NYSE:EMR) Receives Average Recommendation of "Moderate Buy" from Analysts
17 Feb 2025 02:56:12 By Buzz FX
-
Paycom Software, Inc. (NYSE:PAYC) Receives Consensus Recommendation of "Hold" from Analysts
17 Feb 2025 02:56:12 By Buzz FX
-
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Given Consensus Rating of "Moderate Buy" by Analysts
17 Feb 2025 02:56:12 By Buzz FX